AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
From 17 analysts
Fundamentals
Fundamentals institutional score is 100 using growth durability 100.0.
Valuation
Valuation institutional score is 41 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
Analyst View institutional score is 52 using mean target upside 10.9%; dispersion penalty 18.5; recommendation breadth from available consensus.
Technical Structure
Technicals institutional score is 49 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 10 recent ticker-linked news items.
Signal Summary
Market intelligence remains Neutral. fundamentals provide support, while valuation and analyst consensus remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Trading 93.0% above historical median. Valuation is rising — currently in the strongly overvalued zone (z-score: +1.54). Confidence: 50%.
Live forward EPS implies next-12-month EPS of ₹92.86. Applying the stock's normalized valuation corridor produces a fair range of ₹1,146.82 to ₹3,605.75, with base value near ₹2,417.15 (-32.8% vs current price).
Live forward estimate anchored to the company's historical valuation corridor.
Forward EPS
₹92.86
Forward P/E
38.7x
Base Fair Value
₹2,417.15
Fair Range
₹1,146.82 - ₹3,605.75
Upside To Base
-32.8%
Estimate Source
Live forward EPS
Growth Estimate
+62.1%
5Y Average
21.77
Current
18.52
Overvalued
22.56
Undervalued
20.46
5Y Average
18.05
Current
50.25
Overvalued
38.83
Undervalued
12.35
5Y Average
8.71
Current
25.23
Overvalued
14.70
Undervalued
1.44
Peers & Comparison
Sector: Financials · Theme: Stock Exchanges & Ratings
| Company | Rev. Growth | Margin | P/E | vs Avg | 52W Perf. |
|---|---|---|---|---|---|
DR. REDDY S LABORATORIES DRREDDYPharmaceuticals | -5.6% | 10.0% | 29.2x Undervalued | -34% vs avg | -3.9% |
GRASIM INDUSTRIES LTD GRASIMCement | +10.5% | 2.8% | 46.2x Fair | +5% vs avg | +20.4% |
HINDALCO INDUSTRIES LTD HINDALCOMetals - Aluminium | +32.1% | 5.5% | 14.3x Undervalued | -68% vs avg | +57.5% |
CG POWER AND IND SOL LTD CGPOWERHeavy Electrical Equipments | +14.0% | 9.8% | 111.1x Premium | +151% vs avg | +32.2% |
EICHER MOTORS LTD EICHERMOTTrucks & Buses | +31.5% | 23.2% | 38.0x Fair | -14% vs avg | +41.4% |
APOLLO HOSPITALS ENTER. L APOLLOHOSPHospitals & Diagnostic Centres | +18.1% | 7.7% | 66.0x Premium | +49% vs avg | +23.2% |
HCL TECHNOLOGIES LTD HCLTECHIT Services & Consulting | +3.0% | 13.0% | 21.1x Undervalued | -52% vs avg | -8.8% |
BAJAJ AUTO LIMITED BAJAJ-AUTOTwo Wheelers | +64.0% | 16.3% | 27.7x Undervalued | -37% vs avg | +40.9% |
BSE LIMITED trades at a premium (52.3x vs peer avg 44.2x), implying higher growth or quality expectations from the Stock Exchanges & Ratings cohort. Peers include DR. REDDY S LABORATORIES, GRASIM INDUSTRIES LTD, HINDALCO INDUSTRIES LTD — selected based on business model, industry classification, market cap similarity, and business theme alignment.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹1.47K CrJun 2026Latest net profit
₹801 CrJun 2026Latest EPS
₹19.67Jun 2026Net margin
67.0%Jun 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Jun 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 191 | 269 | 320 | 479 | 545 | 659 | 688 | 763 | 873 | 975 | 1,153 | 1,468 | 1,474 |
| Expenses + | 118 | 145 | 173 | 367 | 301 | 357 | 367 | 323 | 316 | 371 | 455 | 487 | 492 |
| Operating Profit | 72 | 124 | 147 | 112 | 245 | 302 | 322 | 440 | 557 | 604 | 698 | 981 | 982 |
| OPM % | 38% | 46% | 46% | 23% | 45% | 46% | 47% | 58% | 64% | 62% | 61% | 67% | 67% |
| Other Income + | 518 | 8 | 7 | 6 | 6 | 96 | 51 | 104 | 91 | 99 | 77 | 115 | 127 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 17 | 18 | 20 | 21 | 19 | 23 | 24 | 24 | 22 | 27 | 39 | 47 | 36 |
| Profit before tax | 573 | 115 | 134 | 97 | 232 | 375 | 349 | 520 | 626 | 676 | 736 | 1,049 | 1,073 |
| Tax % | 12% | 37% | 29% | 18% | 25% | 25% | 25% | 24% | 25% | 24% | 25% | 24% | 25% |
| Net Profit + | 507 | 72 | 95 | 79 | 173 | 282 | 260 | 397 | 468 | 514 | 552 | 799 | 801 |
| EPS in Rs | 12.48 | 1.77 | 2.34 | 1.95 | 4.27 | 6.94 | 6.41 | 9.78 | 11.53 | 12.65 | 13.56 | 19.62 | 19.67 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).